Relay Therapeutics, Inc. (RLAY)
NASDAQ: RLAY · Real-Time Price · USD
19.23
-0.52 (-2.63%)
Aug 7, 2026, 2:38 PM EDT - Market open
Relay Therapeutics Analyst Ratings
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Barclays | Barclays | Buy Maintains $27 → $30 | Buy | Maintains | $27 → $30 | +56.01% | Aug 7, 2026 |
| TD Cowen | TD Cowen | Buy Maintains n/a | Buy | Maintains | n/a | n/a | Aug 7, 2026 |
| JonesTrading | JonesTrading | Buy Maintains $20 | Buy | Maintains | $20 | +4.00% | Aug 7, 2026 |
| J.P. Morgan | J.P. Morgan | Buy Reiterates n/a | Buy | Reiterates | n/a | n/a | Aug 4, 2026 |
| Goldman Sachs | Goldman Sachs | Buy Maintains $22 → $31 | Buy | Maintains | $22 → $31 | +61.21% | Jul 21, 2026 |
| Canaccord Genuity | Canaccord Genuity | Buy Initiates $29 | Buy | Initiates | $29 | +50.81% | Jul 16, 2026 |
| Bank of America Securities | Bank of America Securities | Buy Maintains $21 | Buy | Maintains | $21 | +9.20% | Jun 3, 2026 |
| Guggenheim | Guggenheim | Buy Maintains $22 → $26 | Buy | Maintains | $22 → $26 | +35.21% | May 26, 2026 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 3 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.